Biodesix, Inc.
BDSX
$16.89
$1.6710.97%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.79M | -3.98M | -8.72M | -11.47M | -11.10M |
| Total Depreciation and Amortization | 1.42M | 1.39M | 1.41M | 1.44M | 1.44M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.50M | 1.53M | 1.37M | 1.29M | 1.80M |
| Change in Net Operating Assets | -5.29M | 1.84M | -2.94M | 2.17M | -739.00K |
| Cash from Operations | -10.17M | 778.00K | -8.88M | -6.57M | -8.60M |
| Capital Expenditure | -81.00K | -86.00K | -48.00K | -51.00K | -74.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.00K | -18.00K | -19.00K | -44.00K | -63.00K |
| Cash from Investing | -144.00K | -104.00K | -67.00K | -95.00K | -137.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 10.00M | -- |
| Total Debt Repaid | -5.00K | -5.00K | -4.00K | -5.00K | -7.00K |
| Issuance of Common Stock | 17.57M | 2.32M | 5.18M | 0.00 | 313.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -667.00K | -606.00K | -358.00K | -206.00K | -209.00K |
| Cash from Financing | 16.90M | 1.71M | 4.82M | 9.79M | 97.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.59M | 2.38M | -4.12M | 3.13M | -8.64M |